Amarin Q1 revenue $86M (-9% YoY); lowers FY2023 opex guidance to $270-285M

AMARIN CORP PLCUK

2023-Q1 EPS reported -$0.04 revenue$85,975,000

U.S. net product revenue $82.3M (-7% QoQ); generic competition impacts volume and price.
GAAP net loss $16.5M ($0.04 loss per share) vs loss $31.6M YoY; adjusted net income $7.6M.
Gross margin 55% (70% excluding $12.3M supplier amendment charge) vs 76% prior year.
Lowered 2023 operating expense guidance to $270-285M from $290-305M; cash $304.9M.
Europe early launch VAZKEPA in UK, Sweden, Finland; CSL Seqirus partnership for Australia/NZ.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

AMARIN CORP PLCUK updated its the quarter ended March 31, 2023 guidance (lowered).

Period: the quarter ended March 31, 2023
Guidance: lowered
Result: reported results

Exact text from the filing

On May 3, 2023, Amarin Corporation plc (“ Amarin ”) issued a press release announcing its financial results for the three months ended March 31, 2023 (the “ Press Release ”). A copy of the Press Release is furnished herewith as Exhibit 99.1.

View on SEC.gov

Browse all earnings releases →

AMARIN CORP PLCUK filing history →

Source: SEC EDGAR

accession 0000950170-23-016878

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.